By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GVK Biosciences today said that it has extended its license for its Clinical Biomarker Database to the US Food and Drug Administration.

The extension is for a license, originally forged in 2007, to the database with FDA's Biomarker Qualification Group.

Financial and other terms of the extension were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.